Daytime Urinary Incontinence Clinical Trial
Official title:
Micturition Reeducation in Children With Cerebral Palsy
This study evaluates the effectiveness of a voiding reeducation program as treatment for incontinence in children with a brain injury.
Children with cerebral palsy (CP) (Rosenbaum, 2007) gain bladder and bowel control at older
age compared to typical developing children (Ozturk, 2006). The incidence of urinary
incontinence during day and night, fecal incontinence and constipation is higher in this
population.
Incontinence in children is often treated with urotherapy. This is a nonsurgical,
nonpharmacological treatment for lower urinary tract dysfunctions. Standard urotherapy is
noninterventional and it includes giving information, instructions, advice regarding
life-style, fluid intake and bladder diaries. Additionally specific interventions can be
used, such as: various forms of pelvic floor training, behavioral modification, biofeedback,
electrical stimulation and catheterization (Neveus, 2006). Recent research has proven
urotherapy to be successful for the treatment of children with daytime incontinence
(Mulders, 2010).
Despite the high prevalence of incontinence in children with CP the possible treatment
strategies in this population are poorly investigated. Far too often, urinary incontinence
in children with CP is considered a normal, unavoidable and even a minor problem.
Aim: Investigate the influence of individualized urotherapy on the (in)continence of
children with CP.
The included children with CP will be randomized and stratified for type of CP and mental
abilities into 2 groups: the intervention group and the control group. The intervention
group will receive immediate therapy. After one year of therapy, a follow- up of 6 months
will be applied. The control group will start 6 months later and information will be used as
control group. Incontinent children without CP will receive therapy and will also act as
control group.
;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment